A splice variant (rs72613567:TA) in HSD17B13, identified in the DiscovEHR study, was associated with reduced ALT/AST levels and improved liver histology in NASH, offering protection against NASH and cirrhosis [243,244]. The gene discussed is HSD17B13; the disease is metabolic dysfunction-associated steatohepatitis.